STOLLA LABORATORY

Platelets are disc-shaped blood cells and are essential for normal blood clotting. Platelet transfusions are given to patients who are at risk for bleeding or are actively bleeding. Blood transfusions are one of the most common hospital procedures. The Stolla lab is determining how long and in which storage solution platelets can be stored to maintain adequate post-storage viability and function. In addition, the lab is working on improving alternative platelet products including frozen, lyophilized and pathogen-reduced platelets for transfusion. Other projects focus on mechanisms of platelet transfusion biology including prevention of alloimmunization, and mechanisms of endothelial support by platelets.

Areas of Study

• Platelet transfusion biology
• Prevention of bleeding and treatment of active bleeding
• Alternative platelet products for transfusion including platelet additive solutions

Dr. Stolla’s Background

• Joined Bloodworks Northwest in September 2016
• 2016: Instructor, Harvard Medical School, Department of Pathology and Laboratory Medicine, Staff Physician, Brigham and Woman’s Hospital, Dana Farber Cancer Institute and Boston Children’s Hospital, Boston, MA
• 2015-2016: Fellowship, Harvard Joint Program in Transfusion Medicine, Boston, MA
• 2012-2015: Residency, Department of Pathology and Laboratory Medicine University of Rochester Medical Center, Rochester, NY
• 2009 -2012: Postdoctoral Research Fellowship, Training Program for Hematologic Research, Cardeza Foundation, Jefferson University, Philadelphia, PA
• 2006-2008: Internship, Department of Medicine / Cardiology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany